Differential proteomic analysis of bronchoalveolar lavage fluid from lung transplant patients with and without chronic graft dysfunction

Clinical Biochemistry

Volumn 45, Issue 3, 2012, Pages 223-230

  Kosanam, Hari ^a   Sato, Masaaki ^b   Batruch, Ihor ^a   Smith, Chris ^a   Keshavjee, Shaf ^b   Liu, Mingyao ^b   Diamandis, Eleftherios P ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Biomarkers; Bronchoalveolar lavage fluid; Chronic graft dysfunction; Lung transplantation; Mass spectrometry; Multidimensional chromatography; Pathway analysis

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; CARBOXYPEPTIDASE; COMPLEMENT COMPONENT C3; HEAT SHOCK PROTEIN; HISTONE; MUCIN; PROTEIN S 100; PROTEOME; RIBOSOME PROTEIN; TRANSFERRIN; TRIACYLGLYCEROL LIPASE; TRYPSIN;

ARTICLE; CELL INTERACTION; CELL METABOLISM; CELL MIGRATION; CHRONIC DISEASE; FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; GRAFT DYSFUNCTION; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG ALVEOLUS; LUNG LAVAGE; LUNG TRANSPLANTATION; MASS SPECTROMETER; MASS SPECTROMETRY; MOLECULAR WEIGHT; OXIDATIVE STRESS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE;

BILE; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, LIQUID; CHRONIC DISEASE; HUMANS; LUNG TRANSPLANTATION; MASS SPECTROMETRY; PEPTIDES; PRIMARY GRAFT DYSFUNCTION; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; STOMACH;

EID: 84856456515     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.11.015     Document Type: Article

References (42)

1. Trummer M.J. Transplantation of the lung: a review. Rev Surg 1965, 22:87-93.
2. Morton J., Glanville A.R. Lung transplantation in patients with cystic fibrosis. Semin Respir Crit Care Med 2009, 30:559-568.
3. Wilkes D.S., Egan T.M., Reynolds H.Y. Lung transplantation: opportunities for research and clinical advancement. Am J Respir Crit Care Med 2005, 172:944-955.
4. Waddell T.K., Keshavjee S. Lung transplantation for chronic obstructive pulmonary disease. Semin Thorac Cardiovasc Surg 1998, 10:191-201.
5. Cassivi S.D., Meyers B.F., Battafarano R.J., Guthrie T.J., Trulock E.P., Lynch J.P., et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 2002, 74:1663-1669. [discussion 9-70].
6. Thabut G., Christie J.D., Kremers W.K., Fournier M., Halpern S.D. Survival differences following lung transplantation among US transplant centers. JAMA 2010, 304:53-60.
7. Corris P.A. Lung transplantation. Bronchiolitis obliterans syndrome. Chest Surg Clin N Am 2003, 13:543-557.
8. Paradis I. Bronchiolitis obliterans: pathogenesis, prevention, and management. Am J Med Sci 1998, 315:161-178.
9. Parada M.T., Alba A., Sepulveda C. Bronchiolitis obliterans syndrome development in lung transplantation patients. Transplant Proc 2010, 42:331-332.
10. Estenne M., Maurer J.R., Boehler A., Egan J.J., Frost A., Hertz M., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002, 21:297-310.
11. Sato M., Waddell T.K., Wagnetz U., Roberts H.C., Hwang D.M., Haroon A., et al. J Heart Lung Transplant 2011, 7:735-742.
12. Wattiez R., Falmagne P. Proteomics of bronchoalveolar lavage fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2005, 815:169-178.
13. Lin J.L., Bonnichsen M.H., Nogeh E.U., Raftery M.J., Thomas P.S. Proteomics in detection and monitoring of asthma and smoking-related lung diseases. Expert Rev Proteomics 2010, 7:361-372.
14. Wu J., Kobayashi M., Sousa E.A., Liu W., Cai J., Goldman S.J., et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics 2005, 4:1251-1264.
15. Chen H., Wang D., Bai C., Wang X. Proteomics-based biomarkers in chronic obstructive pulmonary disease. J Proteome Res 2010, 9:2798-2808.
16. Gharib S.A., Vaisar T., Aitken M.L., Park D.R., Heinecke J.W., Fu X. Mapping the lung proteome in cystic fibrosis. J Proteome Res 2009, 8:3020-3028.
17. Kinnula V.L., Ishikawa N., Bergmann U., Ohlmeier S. Proteomic approaches for studying human parenchymal lung diseases. Expert Rev Proteomics 2009, 6:619-629.
18. Chang D.W., Hayashi S., Gharib S.A., Vaisar T., King S.T., Tsuchiya M., et al. Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome. Am J Respir Crit Care Med 2008, 178:701-709.
19. Archimandriti D.T., Dalavanga Y.A., Cianti R., Bianchi L., Manda-Stachouli C., Armini A., et al. Proteome analysis of bronchoalveolar lavage in individuals from Metsovo, nonoccupationally exposed to asbestos. J Proteome Res 2009, 8:860-869.
20. de Torre C., Ying S.X., Munson P.J., Meduri G.U., Suffredini A.F. Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics 2006, 6:3949-3957.
21. Nelsestuen G.L., Martinez M.B., Hertz M.I., Savik K., Wendt C.H. Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 2005, 5:1705-1713.
22. Zhang Y., Wroblewski M., Hertz M.I., Wendt C.H., Cervenka T.M., Nelsestuen G.L. Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomics 2006, 6:1001-1010.
23. Meloni F., Salvini R., Bardoni A.M., Passadore I., Solari N., Vitulo P., et al. Bronchoalveolar lavage fluid proteome in bronchiolitis obliterans syndrome: possible role for surfactant protein A in disease onset. J Heart Lung Transplant 2007, 26:1135-1143.
24. Patel J.M., Hu H., Lu L., Deem A., Akindipe O., Brantly M., et al. Thioredoxin as a biomarker for graft rejection in lung transplant recipients. Biomarkers 2008, 13:486-495.
25. Nord M., Schubert K., Cassel T.N., Andersson O., Riise G.C. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients. Transplantation 2002, 73:1264-1269.
26. Hubner R.H., Meffert S., Mundt U., Bottcher H., Freitag S., El Mokhtari N.E., et al. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J 2005, 25:494-501.
27. Han X., Aslanian A., Yates J.R. Mass spectrometry for proteomics. Curr Opin Chem Biol 2008, 12:483-490.
28. Croce K., Gao H., Wang Y., Mooroka T., Sakuma M., Shi C., et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009, 120:427-436.
29. Morrow D.A., Wang Y., Croce K., Sakuma M., Sabatine M.S., Gao H., et al. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. Am Heart J 2008, 155:49-55.
30. Saha S., Harrison S.H., Shen C., Tang H., Radivojac P., Arnold R.J., et al. HIP2: an online database of human plasma proteins from healthy individuals. BMC Med Genomics 2008, 1:12.
31. Lee K., Kye M., Jang J.S., Lee O.J., Kim T., Lim D. Proteomic analysis revealed a strong association of a high level of alpha1-antitrypsin in gastric juice with gastric cancer. Proteomics 2004, 4:3343-3352.
32. Zhou H., Chen B., Li R.X., Sheng Q.H., Li S.J., Zhang L., et al. Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach. Rapid Commun Mass Spectrom 2005, 19:3569-3578.
33. Casals C., Varela A., Ruano M.L., Valino F., Perez-Gil J., Torre N., et al. Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am J Respir Crit Care Med 1998, 157:43-49.
34. Hohlfeld J.M., Tiryaki E., Hamm H., Hoymann H.G., Krug N., Haverich A., et al. Pulmonary surfactant activity is impaired in lung transplant recipients. Am J Respir Crit Care Med 1998, 158:706-712.
35. Mohammed A., Neujahr D.C. Gastroesophageal reflux disease and graft failure after lung transplantation. Transplant Rev (Orlando) 2010, 24:99-103.
36. D'Ovidio F., Mura M., Tsang M., Waddell T.K., Hutcheon M.A., Singer L.G., et al. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg 2005, 129:1144-1152.
37. Ganter B., Zidek N., Hewitt P.R., Muller D., Vladimirova A. Pathway analysis tools and toxicogenomics reference databases for risk assessment. Pharmacogenomics 2008, 9:35-54.
38. Lega M., Dauber J.H., Urch S.E., Banas R., Whiteside T.L., Griffith B.P. Tumor necrosis factor-alpha production by alveolar macrophages in heart-lung transplant recipients. Am Rev Respir Dis 1992, 145:1036-1041.
39. Gray T., Coakley R., Hirsh A., Thornton D., Kirkham S., Koo J.S., et al. Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1beta in human bronchial epithelia. Am J Physiol 2004, 286:L320-L330.
40. Riise G.C., Williams A., Kjellstrom C., Schersten H., Andersson B.A., Kelly F.J. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. Eur Respir J 1998, 12:82-88.
41. Cabrera S., Gaxiola M., Arreola J.L., Ramírez R., Jara P., D'Armiento J., et al. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin. Int J Biochem Cell Biol 2007, 39:2324-2338.
42. Ohmori K., Takeda S., Miyoshi S., Minami M., Nakane S., Ohta M., et al. Attenuation of lung injury in allograft rejection using NF-kappaB decoy transfection-novel strategy for use in lung transplantation. Eur J Cardiothorac Surg 2005, 27:23-27.